SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Andrew J. Leidner, Harrell W. Chesson, Fujie Xu, John W. Ward, Philip R. Spradling, Scott D. Holmberg, Cost-effectiveness of hepatitis C treatment for patients in early stages of liver disease, Hepatology, 2015, 61, 6
  2. 2
    Barbara J. Turner, Barbara S. Taylor, Joshua T. Hanson, Mary Elizabeth Perez, Ludivina Hernandez, Roberto Villarreal, Poornachand Veerapaneni, Kristin Fiebelkorn, Implementing hospital-based baby boomer hepatitis c virus screening and linkage to care: Strategies, results, and costs, Journal of Hospital Medicine, 2015, 10, 8
  3. 3
    David B. Rein, John S. Wittenborn, Bryce D. Smith, Danielle K. Liffmann, John W. Ward, The Cost-effectiveness, Health Benefits, and Financial Costs of New Antiviral Treatments for Hepatitis C Virus, Clinical Infectious Diseases, 2015, 61, 2, 157

    CrossRef

  4. 4
    Hamish A. Innes, Scott A. McDonald, John F. Dillon, Sam Allen, Peter C. Hayes, David Goldberg, Peter R. Mills, Stephen T. Barclay, David Wilks, Heather Valerio, Ray Fox, Diptendu Bhattacharyya, Nicholas Kennedy, Judith Morris, Andrew Fraser, Adrian J. Stanley, Peter Bramley, Sharon J. Hutchinson, Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause-specific outcomes, Hepatology, 2015, 62, 2
  5. 5
    D. A. Axelrod, N. Dzebisashvili, K. Lentine, D. L. Segev, R. Dickson, E. Tuttle-Newhall, R. Freeman, M. Schnitzler, Assessing Variation in the Costs of Care Among Patients Awaiting Liver Transplantation, American Journal of Transplantation, 2014, 14, 1
  6. 6
    Ana Cláudia de Oliveira, Ana Clara Bortotti, Nathália Neves Nunes, Ibrahin A.H. El Bacha, Edison Roberto Parise, Association between age at diagnosis and degree of liver injury in hepatitis C, The Brazilian Journal of Infectious Diseases, 2014, 18, 5, 507

    CrossRef

  7. 7
    Bryce D. Smith, Anthony K. Yartel, Comparison of Hepatitis C Virus Testing Strategies, American Journal of Preventive Medicine, 2014, 47, 3, 233

    CrossRef

  8. 8
    S. Deuffic-Burban, S. Cossais, Y. Yazdanpanah, Coût-efficacité et VHC : mise au point, Journal des Anti-infectieux, 2014, 16, 2, 50

    CrossRef

  9. 9
    Francesco Negro, Epidemiology of hepatitis C in Europe, Digestive and Liver Disease, 2014, 46, S158

    CrossRef

  10. 10
    Philip McEwan, Thomas Ward, Chien-Jen Chen, Mei-Hsuan Lee, Hwai-I Yang, Ray Kim, Gilbert L’Italien, Yong Yuan, Estimating the Incidence and Prevalence of Chronic Hepatitis C Infection in Taiwan Using Back Projection, Value in Health Regional Issues, 2014, 3, 5

    CrossRef

  11. 11
    Andrew S. deLemos, Raymond T. Chung, Hepatitis C treatment: an incipient therapeutic revolution, Trends in Molecular Medicine, 2014, 20, 6, 315

    CrossRef

  12. 12
    Sumeet K. Asrani, Gary L. Davis, Impact of Birth Cohort Screening for Hepatitis C, Current Gastroenterology Reports, 2014, 16, 4

    CrossRef

  13. 13
    Zobair M. Younossi, Mendel E. Singer, Heshaam M. Mir, Linda Henry, Sharon Hunt, Impact of interferon free regimens on clinical and cost outcomes for chronic hepatitis C genotype 1 patients, Journal of Hepatology, 2014, 60, 3, 530

    CrossRef

  14. 14
    Tarik Asselah, Ponni V Perumalswami, Douglas Dieterich, Is screening baby boomers for HCV enough? A call to screen for hepatitis C virus in persons from countries of high endemicity, Liver International, 2014, 34, 10
  15. 15
    Hamish Innes, David Goldberg, Geoffrey Dusheiko, Peter Hayes, Peter R. Mills, John F. Dillon, Esther Aspinall, Stephen T. Barclay, Sharon J. Hutchinson, Patient-important benefits of clearing the hepatitis C virus through treatment: A simulation model, Journal of Hepatology, 2014, 60, 6, 1118

    CrossRef

  16. 16
    Zachary A. Zator, Raymond T. Chung, After the Cure: Management of HCV After Achievement of SVR, Current HIV/AIDS Reports, 2013, 10, 4, 428

    CrossRef

  17. You have free access to this content17
    Z. M. Younossi, M. Stepanova, F. Nader, Z. Younossi, E. Elsheikh, Associations of chronic hepatitis C with metabolic and cardiac outcomes, Alimentary Pharmacology & Therapeutics, 2013, 37, 6
  18. 18
    Dawn M Sears, Dan C Cohen, Kimberly Ackerman, Jessica E Ma, Juhee Song, Birth Cohort Screening for Chronic Hepatitis During Colonoscopy Appointments, The American Journal of Gastroenterology, 2013, 108, 6, 981

    CrossRef

  19. 19
    Omar T. Sims, Christopher C. Whalen, Larry G. Nackerud, Brian E. Bride, Birth Cohort Testing for Hepatitis C Virus: Implications for Clinical Social Workers in Health Care Settings, Social Work in Health Care, 2013, 52, 8, 689

    CrossRef

  20. 20
    Homie Razavi, Antoine C. ElKhoury, Elamin Elbasha, Chris Estes, Ken Pasini, Thierry Poynard, Ritesh Kumar, Chronic hepatitis C virus (HCV) disease burden and cost in the United States, Hepatology, 2013, 57, 6
  21. 21
    M. H. Eckman, A. H. Talal, S. C. Gordon, E. Schiff, K. E. Sherman, Cost-effectiveness of Screening for Chronic Hepatitis C Infection in the United States, Clinical Infectious Diseases, 2013, 56, 10, 1382

    CrossRef

  22. 22
    David A. Axelrod, Economic and financial outcomes in transplantation, Current Opinion in Organ Transplantation, 2013, 18, 2, 222

    CrossRef

  23. 23
    Dawn M Torres, Stephen A Harrison, Editorial: Killing Two Birds With One Stone: Screening for Chronic Hepatitis C at the Time of Colonoscopy in the Baby Boomer Cohort, The American Journal of Gastroenterology, 2013, 108, 6, 990

    CrossRef

  24. 24
    Robert S. Rahimi, Don C. Rockey, End-stage liver disease complications, Current Opinion in Gastroenterology, 2013, 29, 3, 257

    CrossRef

  25. 25
    Philippe Mathurin, HCV burden in Europe and the possible impact of current treatment, Digestive and Liver Disease, 2013, 45, S314

    CrossRef

  26. You have free access to this content26
    Brian R. Edlin, Hepatitis C screening: Getting it right, Hepatology, 2013, 57, 4
  27. 27
    Reena Mahajan, Stephen J. Liu, R. Monina Klevens, Scott D. Holmberg, Indications for Testing Among Reported Cases of HCV Infection From Enhanced Hepatitis Surveillance Sites in the United States, 2004–2010, American Journal of Public Health, 2013, 103, 8, 1445

    CrossRef

  28. 28
    Susan JM Hahné, Irene K Veldhuijzen, Lucas Wiessing, Tek-Ang Lim, Mika Salminen, Marita van de Laar, Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening, BMC Infectious Diseases, 2013, 13, 1, 181

    CrossRef

  29. 29
    Z. M. Younossi, M. Stepanova, M. Afendy, B. P. Lam, A. Mishra, Knowledge about infection is the only predictor of treatment in patients with chronic hepatitis C, Journal of Viral Hepatitis, 2013, 20, 8
  30. 30
    Anthony Loria, Carey Escheik, N. Lynn Gerber, Zobair M. Younossi, Quality of Life in Cirrhosis, Current Gastroenterology Reports, 2013, 15, 1

    CrossRef

  31. 31
    Phil McEwan, Thomas Ward, Yong Yuan, Ray Kim, Gilbert L'Italien, The impact of timing and prioritization on the cost-effectiveness of birth cohort testing and treatment for hepatitis C virus in the United States, Hepatology, 2013, 58, 1
  32. 32
    Marie-Louise Vachon, Douglas T. Dieterich, A great time to invest in baby Boomer's hepatitis C!, Hepatology, 2012, 56, 4
  33. 33
    John W. Ward, David B. Rein, Bryce D. Smith, Data to Guide the “Test and Treat Era” of Hepatitis C, Gastroenterology, 2012, 143, 4, 887

    CrossRef

  34. You have free access to this content34
    Scott W. Biggins, Kiran M. Bambha, Norah A. Terrault, John Inadomi, Stephen Shiboski, Jennifer L. Dodge, Jane Gralla, Hugo R. Rosen, John P. Roberts, Projected future increase in aging hepatitis C virus–infected liver transplant candidates: A potential effect of hepatocellular carcinoma, Liver Transplantation, 2012, 18, 12
  35. 35
    George Papatheodoridis, Angelos Hatzakis, Public health issues of hepatitis C virus infection, Best Practice & Research Clinical Gastroenterology, 2012, 26, 4, 371

    CrossRef